Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: paclitaxel|DRUG: sorafenib tosylate
Sponsor: University of Texas Southwestern Medical Center